Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trial.
John T LangfittMark QuiggGuofen YanWei YuMariann M WardNicholas M BarbaroEdward F ChangDonna K BroshekKenneth D LaxerAndrew J ColePenny K SneedChristopher HessManjari TripathiChristiaanne N HeckJohn W MillerPaul A GarciaAndrew McEvoyNathan B FountainVicenta SalanovaRobert C KnowltonAnto BagićThomas HenrySiddharth KapoorGuy McKhannAdriana E PaladeMarkus ReuberEvelyn Tecomanull nullPublished in: Epilepsia (2019)
Lower initial costs of SRS for medial temporal lobe epilepsy were largely offset by hospitalization costs related to adverse events later in the course of follow-up. Future studies of less-invasive alternatives to ATL will need to assess adverse events and major costs systematically and prospectively to understand the economic implications of adopting these technologies.